PACS vs. OPCH, GH, RDNT, BTSG, SHC, SGRY, PRVA, CON, LFST, and WGS
Should you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and GeneDx (WGS). These companies are all part of the "healthcare" industry.
PACS Group vs. Its Competitors
PACS Group (NYSE:PACS) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, community ranking, earnings, analyst recommendations and dividends.
PACS Group presently has a consensus target price of $34.29, suggesting a potential upside of 223.15%. Option Care Health has a consensus target price of $35.50, suggesting a potential upside of 11.39%. Given PACS Group's higher possible upside, research analysts clearly believe PACS Group is more favorable than Option Care Health.
In the previous week, Option Care Health had 4 more articles in the media than PACS Group. MarketBeat recorded 5 mentions for Option Care Health and 1 mentions for PACS Group. Option Care Health's average media sentiment score of 1.71 beat PACS Group's score of 0.10 indicating that Option Care Health is being referred to more favorably in the news media.
Option Care Health has higher revenue and earnings than PACS Group.
Option Care Health has a net margin of 4.37% compared to PACS Group's net margin of 0.00%. Option Care Health's return on equity of 15.30% beat PACS Group's return on equity.
98.1% of Option Care Health shares are held by institutional investors. 0.6% of Option Care Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
PACS Group has a beta of 0.21, meaning that its share price is 79% less volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500.
Option Care Health received 41 more outperform votes than PACS Group when rated by MarketBeat users. However, 95.83% of users gave PACS Group an outperform vote while only 64.00% of users gave Option Care Health an outperform vote.
Summary
Option Care Health beats PACS Group on 14 of the 16 factors compared between the two stocks.
Get PACS Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
PACS Group Competitors List
Related Companies and Tools
This page (NYSE:PACS) was last updated on 6/12/2025 by MarketBeat.com Staff